dr. hussain on potential of enzalutamide in prostate cancer
Published 5 years ago • 870 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
0:53
dr. freedland on real-world utility of enzalutamide in prostate cancer
-
1:18
dr. hussain on the clinical impact of the profound trial in mcrpc
-
1:32
dr. hussain discusses parp inhibitors in prostate cancer
-
1:11
dr. maha hussain on novel approaches in prostate cancer
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
1:01
dr. hussain on interest in using parp inhibitors in prostate cancer
-
1:03
dr. daniel petrylak on the role of enzalutamide in prostate cancer
-
1:51
dr. hussain discusses findings with parp inhibitors in prostate cancer
-
1:35
dr. hussain on the importance of next generation sequencing in prostate cancer
-
21:25
an update on the prosper trial: focusing on nonmetastatic crpc
-
0:44
dr. gomella on enzalutamide in prostate cancer
-
1:33
dr. hussain on the implications of the profound trial in mcrpc
-
2:39
dr. hussain on ets gene fusions as a predictive biomarker in prostate cancer
-
1:24
dr. stenzl on the safety profile of enzalutamide/adt in mhspc
-
1:12
dr. dreicer on the current role of abiraterone and enzalutamide in prostate cancer
-
0:53
embark: subset analysis of enzalutamide versus leuprolide in prostate cancer
-
1:03
dr. azad on the benefit of adding enzalutamide to adt in mhspc
-
2:21
dr. hussain on the treatment of nonmetastatic crpc
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer